Skip to Main Content

Paper Details

Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
Mod Pathol
22
2017
B, GATA3, HER2, HER2+, Luminal, Luminal B, MAP2K4, MAP2K4 mutations, Male Breast Cancer, Male breast cancer, PIK3CA, TP53, breast cancer, breast cancer precursor lesions, columnar, columnar cell-like lesion, columnar cell-like lesions, ductal carcinoma in situ, estrogen, estrogen receptor, invasive breast cancer, invasive male breast cancer, lobular carcinoma in situ, male breast cancer, men, patients, precursor lesion, progesterone, progesterone receptor
Author NameAffiliation
Leen Slaets
Fatima CardosoChampalimaud Clinical Center/Champalimaud Foundation
Sharon H GiordanoDepartments of Health Services Research and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center
Sharon H GiordanoDepartments of Health Services Research and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center
John M S BartlettOntario Institute for Cancer Research, Canada & University of Edinburgh
Konstantinos Tryfonidis
Carolien P Schr??derUniversity Medical Center Groningen
Carolien P Schr??der
Christi J van AsperenLeiden University Medical Center
Christi J van Asperen
Barbro LinderholmSahlgrenska University Hospital
Kim BensteadCheltenham General Hospital
Paul J van DiestUniversity Medical Center Utrecht
John W M MartensErasmus MC Cancer Institute, Erasmus University Medical Center
John W M Martens
Carolien H M van DeurzenErasmus MC Cancer Institute, Erasmus University Medical Center
Carolien H M van Deurzen
  • 1 - 17

Datasets

Release 1.2